Alebund Pharmaceuticals is an integrated biopharmaceutical company dedicated to developing innovative therapies for renal diseases and related chronic conditions. The company focuses on advancing its pipeline of treatments, including a best-in-class iron-based phosphate binder and a first-in-class pan phosphate transporter inhibitor, while also expanding the commercial reach of its products in China and globally.
Leadership & Board
Key Executives
Co-Founder and Chief Medical OfficerJin Tian
Co-Founder and Chief Executive OfficerGavin Xia
Current Number of Employees15
Current LinkedIn Followers132
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$550M
Total Amount Raised$550M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$550M
Latest Funding Amount$550M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Alebund Pharmaceuticals had 15 employees as of April 27, 2026. The number of employees decreased by 1 (6.25%) week-over-week.
15Latest Employee Count
1(-6.25%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Alebund Pharmaceuticals had 132 followers as of April 27, 2026. The number of followers increased by 3 (2.33%) week-over-week.
132Latest Followers Count
3(2.33%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.